Home > Request Information
Title:
Abivax’s Covid-19 Phase 2b/3 miR-AGE Trial with ABX464 Declared Research National Priority
* Company:
* Country:
* Name:
Job Title:
* Tel:
Fax:
* E-mail:
Message:
Verification Code:
refresh